[Pubmed] Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylchol
Posté : 11 avr. 2024 12:00
J Neurol. 2024 Apr 11. doi: 10.1007/s00415-024-12367-4. Online ahead of print.
NO ABSTRACT
PMID:38602546 | DOI:10.1007/s00415-024-12367-4
Source: https://pubmed.ncbi.nlm.nih.gov/3860254 ... t9+e462414